Abstract
HDR brachytherapy is one of the effective approaches for safely delivering greater doses to the target, and has been used as a boost to EBRT for localized prostate cancer. We have reported the existence of a correlation between the severity of acute GU toxicity and the urethral dose in HDR brachytherapy using post-operative CT-based planning (Akimoto T et al., IJROBP 63, 2005 and IJROBP 64, 2005), and that the use of anatomy-based inverse optimization (IO) was associated with reduced incidence of grade 2 or worse acute GU toxicity compared to that of geometrical optimization, consistent with a reduction of the urethral dose (Akimoto T et al.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
